Opioids Market Segmentation:
Duration of Action Segment Analysis
Based on the duration of action, the ER / long-acting opioids segment is predicted to capture the largest share at 55% in the opioids market over the assessed period. Extended-release is far in the lead due to long-lasting chronic pain. The requirement for surgical aftercare. Oxycodone, hydrocodone, and fentanyl, long-acting and preferred for continuing pain control in oncology and post-op cases. Estimates by the CDC show that 58% of adults in the U.S. are living with chronic conditions such as cancer or cardiovascular disease. This supports the need for ER opioids.
Application Segment Analysis
In terms of application, the pain management segment is anticipated to hold the highest revenue proportion of 74% in the opioids market throughout the discussed timeline. Opioids continue to be an integral component of pain management for postoperative, cancer, and chronic pain. There are an estimated 300 million surgeries performed worldwide each year. This can account for the continued high utilization of opioids for pain. Opioids are a class of potent analgesics used to manage moderate to severe pain.
Our in-depth analysis of the global opioids market includes the following segments:
|
Segment |
Subsegments |
|
Type |
|
|
Duration |
|
|
Application |
|
|
Route |
|
|
Distribution |
|
